JKK MUNIRAJAH MEDICAL RESEARCH FOUNDATION'S

ANNAI JKK SAMPOORANI AMMAL COLLEGE OF PHARMACY

Approved by PCI,New Delhi, Affiliated to The Tamilnadu Dr. M.G.R.Medical University, Chennai

Pharmaceutics & Pharmaceutical Regulatory Affairs

Introduction

                                           DF0A9140.JPG (8.29 MB)

The Department of Pharmaceutics and Drug Regulatory Affairs are part of JKKMMRF'S ANNAI JKK SAMPOORANI AMMAL College of Pharmacy, Komarapalayam, collectively has 16 competent faculty members, where the quality and achievement of our faculty shows a commitment to excellence in academia, research and development is demonstrated through the productivity and success of our faculty and students.

Pharmaceutics is the discipline of pharmacy that deals with the science of dosage form design and embraces all facets of the process of turning a new chemical entity (NCE) into a medication that can be safely and effectively used by patients in the community.

The Drug Regulatory Affairs (DRA) refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation. The pharmaceutical law frame, guidelines covering Quality, Safety and Efficacy as well as Health Authorities' attitudes and requirements etc. have a great influence on the drug development process and the success of it. It professional plays an important role in every phase, from developing regulatory strategies following the discovery of a new chemical entity to planning post-marketing activities. The Department's mission is teaching and scientific research. The Department has remarkable research activities and excel in publishing wide range of research articles every year in well reputed peer reviewed indexed journals. Also, it has an excellent placement track record.

The Department has state-of- the art labs, modern facilities and well experienced staffs. It offers the students and research scholars to enrich their skill and knowledge in all disciplines from Preformulation studies, development of various dosage forms. Our department is responsible for teaching physical pharmacy, different pharmaceutical dosage forms, biopharmaceutics, pharmacokinetics, quality control, and manufacturing processes.

Vision & Mission

Vision :

  • The Department of Pharmaceutics is committed to create highly trained, versatile, ethical professionals needed for providing quality medicines for health care services.
  • To get recognized as a top-tier education and research center in pharmaceutics through innovative approaches in teaching, training, and research.

Mission :

  • To provide adequate knowledge & skills to develop quality medicines & cosmetics.
  • To update the students with recent technology in the area of pharmaceutical manufacturing.
  • To create value based leadership in pharmaceutical care.
  • Enrich the professional knowledge through problem solving attitude.
  • To assure quality of pharmaceutical formulation offering improved patient compliance & therapeutic efficacy.

HOD Profile

 

PHARMACEUTICS & PHARMACEUTICAL REGULATORY AFFAIRS

 

HOD Profile

Name                         :           Dr.S.Chandra

Qualification            :           M.Pharm., Ph.D., D.Lit (London)

Department              :           Pharmaceutics

Designation             :           Professor and Head

Date of Joining       :           18.12.2006 

DF0A2563 1.jpg (408 KB) 

Dr.S.Chandra, M.Pharm., Ph.D., D.Lit (London)

Professor and Head

Field of Specialization

Pharmaceutics

Phone No.

9789456750

E-Mail

chandrajkkm@gmail.com

Residential Address

39/3A4., Easwari Garden,

Kesavan Nagar.,

Kannakurichi P.O

Salem. 636 008

Experience

18 yrs

Blood Group

B+ Positive

 

Area of Research

Ø  Floating drug delivery system

Ø  Nano particle

Ø  Hydrogel

Ø  Nano-Composite drug delivery. 

Publication Details : 

International                         :           17

National                               :            41

 

Project details   : 

UG                                          :           17

PG                                          :           51

 

Book Published                  :           5

Awards received                :           4

 

Conference/ Workshop/ Symposium/ Seminar/FDP Attended                  :           63

Conference/ Workshop/ Symposium/ Seminar/FDP Conducted              :           4

Resource Person in Conference/ Workshop/ Symposium/ Seminar/FDP  :      1

 

Membership Details           :              APTI               :           TN/LMNo-354

                                                            IPGA               :           LMNo-428

                                                            IPA                  :           LM.No-TN589

 

Staffs

Area of Research

Pharmaceutical Research & Development Cell co-ordinates sponsored research, collaborative research and industrial consultancy projects at JKKMMRF’s Annai JKK Sampoorani Ammal college of Pharmacy. Through such projects, the Institute is strengthening the Research & Development capabilities of the faculty and students and participates in Industry relevant problem solving. Institute has experienced academicians and researchers from various R&D units of the country. In making our vision and mission a reality, the Institution has taken the initiative to promote innovation ideas of faculty and students and collaborate with Industries for mutual benefit. Committed to excellence in fundamental research as well as the development of innovative technologies for the future, the Institution offers a quality research training experience for its students.

The Institute maintains its relevance to world-class research by linking with industry and academia through local and international research networks. Preformulation studies , preparation , stability studies , evaluation of drugs using in laboratories as well as industries for sustained drug release , extended drug release , floating drug delivery system. More than 100 Various journals and articles published in various websites .

Instruments for formulation and evaluations

  • TABLET MULTIPUNCHING MACHINE
  • BROOK FIELD VISCOMETER
  • GLASS DISTILLATION APPARATUS
  • UV- VISIBLE SPECTROPHOTOMETRY
  • DISINTEGRATION TEST APPARATUS
  • DISSOLUTION APPARATUS
  • BOTTLE WASHING MACHINE
  • ULTRA SONICATOR
  • TINCTURE PRESS
  • BALL MILL
  • CUTTER MILL
  • OINTMENT FILLING MACHINE
  • LIQUID FILLING MACHINE
  • SIEVE SHAKER
  • LAMINAR AIR FLOW
  • KALWEKA UNIT
  • PH METER
  • B.O.D INCUBATOR
  • PAN COATING
  • SINGLE TABLET PUNCHING MACHINE

RESEARCH GUIDE

S.NO Name of the Supervisor University Department Research Area E-Mail-ID
1 Dr.S.Chandra The Tamil Nadu Dr MGR Medical University Pharmaceutics Pharmaceutical science chandrajkkm@gmail.com

AREA RESEARCH AND DEVELOPMENT

  • Floating Drug Delivery
  • Sustained Release Tablet
  • Suspension
  • Chewable Tablet Extended-Release Tablet
  • Buccal Tablet
  • Dispersible Tablet Mucoadhesive Drug Delivery
  • Colon Drug Delivery
  • Nanoparticles
  • Trans Dermal Drug Delivery

Events

Academic Year 2021-2022

Date Name of the Add on course/ workshop/ seminar Details of Resource person with designation  No. of participants
09/11/2021 Artificial Neural Network as Helping Tool for Drug Formulation Strategies Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 341
Artificial Neural Networking in Controlled Drug Delivery Dr.N.Senthilkumar, Principal Mr.R.Suresh, Assistant Professor 347
11/11/2021 Neural Networks and Computational Complexity Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 401
Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor 400
17/11/2021 Artificial Neural Networks innovative manufacturing in pharma sector Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 387
ANNs in upstream processes in API manufacturing Dr.V.Suresh., Professor and HOD  Dr.N.Senthilkumar, Principal 384
25/11/2021 ANNs in downstream processes in pharma manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 371
Prospects of Artificial Neural Networks Dr.V.Suresh, Professor and HOD  Dr.N.Senthilkumar, Principal 370
29/11/2021 Prediction of in vitro dissolution by neural network Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 400
Application of Artificial Neural Networks in Modern Drug Discovery Dr.V.Suresh, Professor and HOD  Dr.N.Senthilkumar, Principal 401
07/02/2022 Types of commonly uses simulations in formulation development Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 351
High Performance Computing and Network Simulation in formulation development Dr.N.Senthilkumar, Principal Dr.v.Suresh, Professor and HOD  350
08/02/2022 Problem-solving methodology in formulation development Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 371
Drug–Excipient Interaction and Incompatibilities using computer Simulation Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 370
16/02/2022 Ethics and Legal Protection of Uses of Computer Applications in Pharmaceutical Research Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 400
Dosage Form Design Uses of Computer Simulation Dr.v.Suresh, Professor and HOD  Dr.N.Senthilkumar, Principal 400
23/02/2022 Computer Simulation in Biotechnology-based pharmaceutical production Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 387
Proteins and peptides drug delivery precise prediction using Computer Simulation Dr.V.Suresh., Professor and HOD  Dr.N.Senthilkumar, Principal 388
24/02/2022 Design, discovery, and optimization of new chemical entities using Computer Simulation Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 402
Applications of Modelling and Simulation in pharmaceutical formulations Dr.v.Suresh, Professor and HOD  Dr.N.Senthilkumar, Principal 401
06/08/2022 Pharmaceutical regulatory Affairs A prosperous pathway for next generation career Dr. R. Arun , Director of Yarth life science 567

Academic Year 2020-2021

Date Name of the Add on course/ workshop/ seminar Details of Resource person with designation  No. of participants
15/12/2020 Optimal design concepts used in pharma industry Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 471
Guarantee the product quality through Optimal design Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 471
16/12/2020 Mathematical Models for Optimal design Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 468
Principles of Optimal Design Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 468
17/12/2020 Decision-Making and Design Optimization in pharma industry Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 471
Optimization Methods Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan., Professor 471
29/12/2020 Robust Optimal Design and parameters Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 398
Design of complex systems through Optimal Design Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 398
30/12/2020 Trial-and-error modeling making in Pharma manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 471
Importance of optimal design in pharma industry Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 471
01/03/2021 Population Modeling in pharma Industry Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 384
Population Modeling Based Drug Development Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 384
04/03/2021 Modeling as a tool in drug development Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 470
Modeling and simulation Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 472
10/03/2021 Rational decisions regarding drug use and development using Population Modelling Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 384
Population Modelling in Biopharmaceutics applications Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 382
18/03/2021 The Components of Population Models Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 412
Estimation parameters in the model Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 412
26/03/2021 Graphical evaluations of the data in Population Models Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 407
Software and Modeling Environment Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 408

Academic Year 2019 - 2020

Date Name of the Add on course/ workshop/ seminar Details of Resource person with designation  No. of participants
10/10/2019 Automation technologies help in improving the efficiency of the pharmaceutical development and production Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 471
Advantages of process automation technologies in pharma Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 472
16/10/2019 Process Automation and Equipment Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 309
Improved accuracy, reliability, productivity through Automation Process Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 309
17/10/2019 Common Data Automation Techniques in Pharmaceutical manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 325
Types of automation systems Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 325
29/10/2019 The best automation testing tools Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 361
Artificial intelligence and automation Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 361
30/10/2019 Significance in enabling automation across pharma industries Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 381
The pros and cons of automation in pharma manufacturing Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 380
13/02/2020 Robotics Simulations in pharmaceutical industry Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 374
Robots currently used by the pharmaceutical industry Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 374
18/02/2020 R&D Tests and trials using robots Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 298
The evolution of robotics research Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 300
19/02//2020 Service robotics to the pharmaceutical industry Dr.S.Chandra, Professor and HOD Mr.R.Suresh., Assistant Professor 341
Challenges used robots in pharmaceutical industry Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 341
26/02/2020 Robots in Quality control operations Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 410
Robots in Testing and validation Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 410
27/02/2020 Robotics helps Regulatory compliance Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 374
Advantages and disadvantages of robotics in the pharmaceutical industry Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 371
14/11/2019 Scope of Pharma industry Mr. T. Rajaram, Head of the Industry 421

Academic Year 2018-2019

Date Name of the Add on course/ workshop/ seminar Details of Resource person with designation  No. of participants
04/06/2018 Introduction on   Automation in Pharmaceutical Profiling Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 298
Introduction on Drug Discovery Automation Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 300
05/06/2018 Selection of properties to profile during discovery Dr.S.Chandra, Pofessor and HOD Mr.R.Suresh, Assistant Professor 391
Automation of pharmaceutical property assays Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 391
11/06/2018 Application of Pharmaceutical Profiling Data in Drug Discovery Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 401
Data process, achieve retrieve and report Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 401
18/06/2018 High-capacity detectors in Pharmaceutical Profiling Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 352
Robotic liquid handler Automation in Pharmaceutical Profiling Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 355
23/06/2018 Pharmaceutical profiling in future directions Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 298
Crucial elements of automation for pharmaceutical profiling Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar., Principal 300
02/04/2018 Introduction on Laboratory automation systems Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 426
Pharma Industry lab Automation and standard operating procedures Dr.N.Senthilkumar, Principal Dr.D.Krishnarajan, Professor 426
06/04/2018 Laboratory automation system hardware and software Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 398
New and improved processes analysis of drugs Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor 398
10/04/2018 Re-analytic, analytical, or post-analytical stages in lab automation Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 394
Instrumentation for lab automation processes Dr.D.Krishnarajan., Professor Dr.N.Senthilkumar., Principal 393
17/04/2018 Intelligent integration of robotics and laboratory automation software. Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 274
Automation is the Future of Lab Work Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 274
18/04/2018 Accelerating Drug Discover with Automation lab Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 398
Pros and cons in automation of laboratories Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 394

Academic Year 2017-2018

Date Name of the Add on course/ workshop/ seminar Details of Resource person with designation  No. of participants
21/08/2017 Automation in pharmaceutical profiling and drug discovery Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 382
Pharma Industry Automation and compliance Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal Dr.S.Chandra, Professor and HOD 387
22/08/2017 Artificial Intelligence technology used in the drug designing procedure Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 352
Pharma Manufacturing and Commercialization Softwares Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 350
23/08/2017 Automation in pharmaceutical manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant professor 298
Automation is Changing the Global Pharma Industry Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 299
14/09/2017 Robotic process automation pros and cons in   pharmaceutical manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 387
India Pharmaceutical Adopting Automation Technologies Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 390
15/09/2017 Automating Biopharma Manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 294
Robotic Pharmaceutical Manufacturing Processes for Improved Pharmaceutical Production Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 294
02/11/2017 Lab-scale testing of pharmaceutical materials and products Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 351
Formulation optimization are improved patient safety and compliance Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 357
14/11/2017 Necessity of Optimization Techniques in formulation development Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 418
Optimization process to identify and implement new methods in pharmaceutical manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 417
15/11/2017 Systematic design of experiments by modern approach. Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 402
Design of experiments applied in pharma industry to develop novel formulations Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 402
24/11/2017 Optimization problem in pharmaceutical   manufacturing Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 398
Novel drug delivery design and development using design of experiments Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar, Principal 398
25/11/2017 Computer simulations in optimization of formulation development Dr.S.Chandra, Professor and HOD Mr.R.Suresh, Assistant Professor 452
Optimization problems in developing novel formulations Dr.D.Krishnarajan, Professor Dr.N.Senthilkumar., Principal 457
06/10/2018 Recent trends and scope in pharmaceutics Dr. K.Gowthamrajan , Professor and HOD Dr.V. Senthil, Professor Mr.T. Rajaram, Head of the industry 780

PEO

M.PHARM (PHARMACEUTICS )

PROGRAMME EDUCATIONAL OUTCOMES (PEOs)

PEO - 1

To produce pharmacy post-graduates with strong fundamental concepts and high technical competence in pharmaceutical sciences and technology, who shall be able to use these tools in pharmaceutical industry and/or institutes where ever necessary for success.

PEO - 2

To promote the development of trained human resource in Pharmaceutical Sciences for dissemination of quality education with highly professional and ethical attitude, strong communication skills, effective skills to work in a team with a multidisciplinary approach.

PEO - 3

To generate potential knowledge pools with interpersonal and collaborative skills to identify, assess and formulate problems and execute the solution in closely related pharmaceutical industries.

PROGRAMME SPECIFIC OUTCOMES (PSOs)

PSO - 1

Analyze, criticize, organize, improvise and manage documents, data and information related to pharmaceutical production process.

PSO - 2

Execute team based research to implement innovative solutions in the area of formulation, quality assurance and technology transfer.

 

PROGRAMME OUTCOMES (PO)

M.PHARM (PHARMACEUTICS )

PO - 1

Scientific knowledge: To apply the scientific and technological principles to design, develop effective pharmaceutical dosage forms and drug delivery systems for better therapeutic results.

PO - 2

Technological applications: To utilize technical knowledge and identify any factors affecting the quality of pharmaceutical production.

PO - 3

Modern tool usage: Learn, select, apply appropriate methods, procedures, resources, and modern pharmacy-related computing tools with an understanding of the limitations.

PO - 4

Entrepreneurship: To understand the basics of establishing and management of pharmaceutical enterprise.

PO - 5

Practical skills: To gain practical expertise in formulating and evaluating various novel drug release systems for minor ailments to major diseases.

PO - 6

Applied science: To employ contemporary scientific knowledge viz., pharmacology, biotechnology for designing disease-centric pharmaceuticals.

PO - 7

Computational and statistical methodologies: Applying and utilizing the statistical tools with the aid of computer software to optimize the formulations.

PO - 8

Pharmaceutical ethics: To respect personal values and apply ethical principles in professional and social contexts. Demonstrate behavior that recognizes cultural, personal variability in values, communication and lifestyles. Use ethical frameworks; apply ethical principles while making decisions and take responsibility for the outcomes associated with the decisions.

PO - 9

Environment and sustainability: To understand, protect and cooperate environmental concerns for sustaining biodiversity.

PO - 10

Life-long learning: To develop the habit of updating knowledge from time to time to meet industrial demands and social needs for having a fruitful career.

 

COURSE OUTCOMES

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I)

MPH101T

Modern Pharmaceutical Analytical Techniques

CO - 1

Understand the basic instrumentation of HPTLC, HPLC, GC  for identification, and characterization of compounds

CO - 2

Understand the basic concept and instrumentation of Chromatographic techniques 

CO - 3

Understand the basic principles and instrumentation of fluorimeter and atomic absorption spectrometer

CO - 4

Learn general principles and instrumentation of ion selective electrodes.

CO - 5

Explain Instrumentation, separation and identification of compounds by electrophoresis technique

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I)

MPH102T

Drug Delivery System

CO - 1

The various approaches for development of novel drug delivery systems.

CO - 2

The criteria for selection of drugs and polymers for the development of delivering system

CO - 3

 Evaluate drug delivery systems for physic-chemical characteristics, in vitro and in vivo drug release

CO - 4

Formulate and design controlled release and sustained release drug delivery systems.

CO - 5

Conduct stability studies for dosage forms as per prescribed guidelines

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I)

MPH103T

Modern Pharmaceutics

CO - 1

Perform the  elements of pre formulation studies.

 

CO - 2

Understand the concept of  Active Pharmaceutical Ingredients and Generic drug Product development

CO - 3

Explain the Industrial Management and GMP Considerations.

CO - 4

Understand the concept of Optimization Techniques & Pilot Plant Scale Up Techniques

CO - 5

Describe about  Stability Testing, sterilization process & packaging of dosage forms

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I)

MPH104T

Regulatory Affair

CO - 1

Discuss the regulatory guidance  and guidelines for filing and approval process.

CO - 2

Categorize the preparation of dossiers and their submission to regulatory agencies in different countries

CO - 3

Assess the post approval requirements for actives and drug products

CO - 4

Describe the clinical trials requirements for approvals for conducting clinical trials

CO - 5

Discuss the role of pharmacovigilance and the process of monitoring in clinical trials

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - I)

MPH105P

Pharmaceutics Practical I

CO - 1

Analysis of pharmacopoeial compounds and their formulations by UV Vis spectrophotometer

CO - 2

Experiments based on HPLC

CO - 3

To perform  In-vitro dissolution profile of  CR/ SR  marketed formulation

CO - 4

To carry out preformulation studies of tablets

CO - 5

To plot Heckal plot, Higuchi and peppas plot and determine similarity factors.

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II)

 MPH201T

    Molecular Pharmaceutics (Nano Tech and Targeted DDS)

CO - 1

Understand the basic instrumentation of HPTLC, HPLC, GC  for identification, and characterization of compounds

CO - 2

Understand the basic concept and instrumentation of Chromatographic techniques 

CO - 3

Understand the basic principles and instrumentation of fluorimeter and atomic absorption spectrometer

CO - 4

Learn general principles and instrumentation of ion selective electrodes.

CO - 5

Explain Instrumentation, separation and identification of compounds by electrophoresis technique

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II)

 

MPH202T

Advanced Biopharmaceutics & Pharmacokinetics

CO - 1

Understand basic considerations of pharmacokinetic models. Understand different compartment model and non-compartment model

CO - 2

Explain the design and evaluation of dosage regimens of the drugs using pharmacokinetic and  biopharmaceutical parameters.

CO - 3

Learn different types of drug interactions which alter the pharmacokinetics of such as drug-protein /drug-tissue binding interactions

CO - 4

Elaborate design Bioavailability and Bioequivalence studies of new drugs or dosage forms

CO - 5

Study the application of pharmacokinetics and pharmacodynamics of biotechnology drugs.   

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II)

MPH203T

Computer Aided Drug Delivery System

CO - 1

Know the basic computational modeling principles for drug disposition

CO - 2

Learn computer aided biopharmaceutical characterization of drugs

CO - 3

Learn computer simulation in pharmacokinetics and pharmacodynamics

CO - 4

Study the use of computers in clinical development of drugs

CO - 5

 Understand the need of industrial automation by application of artificial intelligence, robotics and computational fluid dynamics

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II)

MPH204T

Cosmetic and Cosmeceuticals

CO - 1

Describe the regulatory provisions related to the import and manufacture of cosmetics as per the Drugs and Cosmetics Act 1940 and the Rules 1945

CO - 2

Select key ingredients suitable in the formulation of various cosmetics

CO - 3

Design cosmetics and cosmeceuticals with desired safety, stability and efficacy with a knowledge of the various technologies involved in their manufacture

CO - 4

Design cosmeceuticals for sun protection, dry skin, acne, sun-protection, pigmentation, prickly heat, wrinkles, body odor. Dandruff, dental cavities, bleeding gums, mouth odor and sensitive teeth

CO - 5

Select herbal ingredients in the formulation of cosmetics for hair care, skin care and oral care

 

M.PHARM (PHARMACEUTICS ) - YEAR - I (SEMESTER - II)

MPH205P

Pharmaceutics Practical II

CO - 1

To recall the basic techniques for preparation of microspheres, liposomes, niosomes and solid dispersions.

CO - 2

To compare the dissolution studies of various marketed products.

CO - 3

To develop various novel drug delivery systems.

CO - 4

To test for drug binding characteristics, cell permeation and bioavailability of the formulations.

CO - 5

To evaluate the novel drug delivery systems.

 

M.PHARM  - YEAR - II (SEMESTER - III)

COMMON TO ALL BRANCHES

MRM 301T

Research Methodology and Biostatistics

CO - 1

Students should understand a general definition of research design

CO - 2

Students should be able to identify the overall process of designing a research study and the use of various statistical test involved

CO - 3

Students should be familiar with human ethical issues in educational research, including those issues that arise in using quantitative and qualitative research

CO - 4

Students should know the guidelines in performing animal study and maintenance of animal house.

CO - 5

Students should be familiar with declaration of Helsinki

 

M.PHARM  - YEAR - II (SEMESTER - III & IV)

COMMON TO ALL BRANCHES

 

JOURNAL CLUB

CO - 1

Able to collect relevant literature and critically evaluate them

CO - 2

Learnt to make a PPT presentation scientifically and deliver the same

CO - 3

Able to involve effectively in post presentation  discussion

 

M.PHARM  - YEAR - II (SEMESTER - III & IV)

COMMON TO ALL BRANCHES

 

DISCUSSION / PRESENTATION (PROPOSAL PRESENTATION)

CO - 1

Able to select research topic through literature review  

CO - 2

Able to design research methodology

CO - 3

Able to Present the selected research proposal  convincingly

 

M.PHARM  - YEAR - II (SEMESTER - III & IV)

COMMON TO ALL BRANCHES

 

RESEARCH WORK

CO - 1

Able to carry out research work scientifically following research ethics

 

CO - 2

Able to collect date, interpret them using appropriate statistical tools and arrive at conclusion scientifically

CO - 3

 Able to document the research work in the form of thesis in an acceptable format

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS)

PROGRAMME EDUCATIONAL OUTCOMES (PEOs)

PEO - 1

To produce pharmacy post-graduates with strong fundamental concepts and high technical competence in pharmaceutical sciences and technology, who shall be able to use these tools in the pharmaceutical industry and/or institutes where ever necessary for success.

PEO - 2

To promote the development of trained human resources in Pharmaceutical Sciences for dissemination of quality education with a highly professional and ethical attitude, strong communication skills, and effective skills to work in a team with a multidisciplinary approach.

PEO - 3

To generate potential knowledge pools with interpersonal and collaborative skills to identify, assess and formulate problems and execute the solution in closely related pharmaceutical industries.

 

PROGRAMME SPECIFIC OUTCOMES (PSOs)

PSO - 1

Identify and utilize the laws and regulations that apply to the development, testing, and production of new medical products, including medical devices, In-Vitro Diagnostics (IVDs), pharmaceuticals, biotechnology-derived therapeutics, and biologics.

PSO - 2

Demonstrate the ability to investigate case studies related to various regulatory topics (e.g. regulatory submissions, product defect, clinical trials and quality assurance strategies etc.,).

  

PROGRAMME OUTCOMES (PO)

M.PHARM (PHARMACEUTICAL REGUALTORY AFFAIRS)

PO - 1

To make available a pool of competent professionals in the area of Pharmaceutical Regulatory Affairs with fundamental knowledge on Various Good Regulatory Practices in the Healthcare and related industries

PO - 2

Documentation and general principles involved in regulatory writing and submission to agencies.

PO - 3

Audit, inspections, Quality management system and Product Life Cycle Management.

PO - 4

Clinical drug development and research regulations in India, EU and US

PO - 5

Regulations for Drugs, Cosmetics, Medical Devices, Herbals, Biologics, Food and Nutraceuticals in various countries like India, EU, US, Canada, Japan, ASEAN, etc.,

  

COURSE OUTCOMES

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - I)

MRA101T

Good Regulatory Practices

CO - 1

The key elements of current Good Manufacturing Practices, Good Laboratory Practices, Good Automated Laboratory Practices, Good Documentation Practices and Good Regulatory Practices.

CO - 2

The check lists for various Good Pharmaceutical Practices and Prepare SOPs for Good Pharmaceutical Practices

CO - 3

Implement Good Pharmaceutical Practices in the Industries and Prepare for the Audit of the Pharmaceutical Industries.

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - I)

MRA102T

Documentation and Regulatory Writing

CO - 1

Know the various documents pertaining to drugs in pharmaceutical industry

CO - 2

Understand the basics of regulatory compilation

CO - 3

Create and assemble the regulation submission as per the requirements of agencies

CO - 4

Follow up the submissions and post approval document requirements

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - I)

MRA103T

Clinical Research Regulations

CO - 1

History, origin and ethics of clinical and biomedical research and evaluation

CO - 2

Clinical drug, medical device development process and different types and phases of clinical trials

CO - 3

Regulatory requirements and guidance for conduct of clinical trials and research

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - I)

 

MRA 104T

Regulations and Legislation for Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food & Nutraceuticals In India and Intellectual Property Rights

CO - 1

Know different Acts and guidelines that regulate Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food & Nutraceuticals industry in India.

CO - 2

Understand the approval process and regulatory requirements for

CO - 3

Drugs & Cosmetics, Medical Devices, Biologicals & Herbals, and Food& Nutraceuticals

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - I)

MRA105P

Regulatory Affairs Practical I

CO - 1

Students will come to know the different competent regulatory authorities globally.

CO - 2

Students be aware of technical aspects pertaining to the marketing authoritization application (MAA)

CO - 3

The regulatory guidelines and directions framed by the regulatory authorities will be helpful to place the drug products in market for marketing approvals.

CO - 4

Prepare and implement the check lists and SOPs for various Good Regulatory Practices.

CO - 5

Implement Good Regulatory Practices in the Healthcare and related Industries.

CO - 6

Prepare for the readiness and conduct of audits and inspections.

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - II)

MRA201T

Regulatory Aspects of Drugs & Cosmetics

CO - 1

Process of drug discovery and development and generic product development

CO - 2

regulatory approval process and registration procedures for API and drug products in US, EU

CO - 3

Cosmetics regulations in regulated and semi-regulated countries

CO - 4

A comparative study of India with other global regulated markets

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - II)

MRA202T

Regulatory Aspects of Herbal & Biologicals

CO - 1

Know the regulatory Requirements for Biologics and Vaccines 

CO - 2

Understand the regulation for newly developed biologics and biosimilars

CO - 3

Know the pre-clinical and clinical development considerations of biologics

CO - 4

Understand the Regulatory Requirements of Blood and/or Its Components Including Blood Products and label requirements

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - II)

MRA203T

Regulatory Aspects  of Medical Devices

CO - 1

Basics of medical devices and IVDs, process of development, ethical and quality considerations harmonization initiatives for approval and marketing of medical devices and IVDs regulatory approval process for medical devices and IVDs in India, US, Canada, EU, Japan and ASEAN clinical evaluation and investigation of medical devices and IVDs

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - II)

MRA204T

Regulatory Aspects of Food & Nutraceuticals

CO - 1

Know the regulatory Requirements for nutraceuticals.

CO - 2

Understand the regulation for registration and labeling of nutraceuticals and food supplements in India, USA and Europe.

 

M.PHARM (PHARMACEUTICAL REGULATORY AFFAIRS )

YEAR - I (SEMESTER - II)

MRA205P

Regulatory Affairs Practical II

CO - 1

The clear information about the patent laws, intellectual property rights and drug regulation in India and abroad is gained by the students

CO - 2

Upon completion of the course the student shall be able to Know the various documents pertaining to drugs in pharmaceutical industry

CO - 3

Understand the basics of regulatory compilation

CO - 4

Create and assemble the regulation submission as per the requirements of agencies

CO - 5

Follow up the submissions and post approval document requirements

 

PHARM.D

PROGRAMME EDUCATIONAL OUTCOMES (PEOs)

PEO - 1

The student will possess professional knowledge of pharmaceutical sciences and technology applicable in pharmaceutical, healthcare industry, community pharmacy and academia as per the requirement.

PEO - 2

With the grooming and knowledge gained, the student will play a major role as professional Pharmacist in the health care team and participate in implementation of various health programs at large.

PEO - 3

The student will inculcate the urge for lifelong learning and up - gradation to meet the needs of the profession and society.

PROGRAMME SPECIFIC OUTCOMES (PSOs)

PSO - 1

Apply and assess the literature and other research resources to provide evidence-based drug information that meets the needs of patients and other health care providers.

PSO - 2

Discuss how patients and care givers can obtain the most cost-efficient medications and related pharmaceuticals per patient-specific health insurance coverage options.

  

PROGRAMME OUTCOMES (PO)

PHARM D

PO - 1

Pharmacy Knowledge:  Possess knowledge and comprehension of the core and basic knowledge associated with the profession of pharmacy, including biomedical sciences; pharmaceutical sciences; behavioral, social, and administrative pharmacy sciences; and manufacturing practices.

PO - 2

Planning Abilities:   Demonstrate effective planning abilities including time management, resource management, delegation skills and organizational skills. Develop and implement plans and organize work to meet deadlines.

PO - 3

Problem analysis:  Utilize the principles of scientific enquiry, thinking analytically, clearly and critically, while solving problems and making decisions during daily practice. Find, analyze, evaluate and apply information systematically and shall make defensible decisions.

PO - 4

Modern tool us age:  Learn, select, and apply appropriate methods and procedures, resources, and modern pharmacy-related computing tools with an understanding of the limitations.

PO - 5

Leadership skills: Understand and consider the human reaction to change, motivation issues, leadership and team-building when planning changes required for fulfillment of practice, professional and societal responsibilities. Assume participatory roles as responsible citizens or leadership roles when appropriate to facilitate improvement in health and well-being.

PO - 6

Professional Identity:  Understand, analyze and communicate the value of their professional roles in society (e.g. health care professionals, promoters of health, educators, managers, employers, employees)

PO - 7

Pharmaceutical Ethics: Honor personal values and apply ethical principles in professional and social contexts. Demonstrate behavior that recognizes cultural and personal variability in values, communication and lifestyles. Use ethical frameworks; apply ethical principles while making decisions and take responsibility for the outcomes associated with the decisions.

PO - 8

Communication:  Communicate effectively with the pharmacy community and with society at large, such as, being able to comprehend and write effective reports, make effective presentations and documentation, and give and receive clear instructions.

PO - 9

The Pharmacist and society:  Apply reasoning informed by the contextual knowledge to assess societal, health, safety and legal issues and the consequent responsibilities relevant to the professional pharmacy practice.

 

COURSE OUTCOMES

PHARM D - Ist YEAR

1.2

Pharmaceutics (THEORY)

CO - 1

Understand the basics of different dosage forms.

CO - 2

Understand the professional way of handling the prescription

CO - 3

Prepare various conventional dosage forms

CO - 4

Develop a clear idea about Pharmaceutical incompatibility and  different

pharmaceutical calculations in pharmacy.

CO - 5

 Predict the instability problems in heterogeneous dosage forms

 

 

1.2

Pharmaceutics (PRACTICAL)

CO - 1

 Understand the professional way of preparing a prescription

CO - 2

 Prepare various liquid dosage forms

CO - 3

 Prepare various solid dosage forms

CO - 4

 Acquire the knowledge of using equipment’s in pharmaceutical industry

CO - 5

Develop a clear idea about Pharmaceutical incompatibility and   different pharmaceutical calculations in pharmacy.

 

PHARM D – Ist YEAR

1.6

Remedial Mathematics (THEORY)

CO – 1

To understand the role of mathematics in pharmacy

CO – 2

To know about theory and their application in pharmacy

CO – 3

To relate the mathematical tools in the wide professional views and solve problems of trigonometry, calculus and matrices.

CO – 4

To solve the different types of problems by applying theory.

CO – 5

To adopt both conventional and creative techniques to the solutions of mathematical problems.

CO – 6

Apply the range of techniques effectively to solve problems including theory deduction, approximation and simulation.

CO – 7

Gain knowledge on how to solve different types of problems by applying theory and applications of mathematics in pharmacy

 

PHARM D - 2nd YEAR

2.2

Pharmaceutical Microbiology (THEORY)

CO - 1

Know the anatomy, identification, growth factors and sterilization of microorganisms;

CO - 2

 Know the mode of transmission of disease causing microorganism, symptoms of disease, and treatment aspect;

CO - 3

Do cultivation and identification of the microorganisms in the laboratory

CO - 4

Do identification of diseases by performing the diagnostic tests

CO - 5

Appreciate the behavior of motility and behavioral characteristics of microorganisms

 

 

2.2

Pharmaceutical Microbiology (PRACTICAL)

CO - 1

 Discuss about the instruments used in experimental microbiology

CO - 2

Understand the sterilization methods followed in laboratory.

CO - 3

Ability to perform  the staining techniques used in microbiology.

CO - 4

Carry out assay of different antibiotics

CO - 5

Execute different sterility tests and bacteriological analysis of water

 

PHARM D - 3rd YEAR

3.4

Pharmaceutical Jurisprudence (THEORY)

CO - 1

Practice the Professional ethics

CO - 2

Understand the various concepts of the pharmaceutical legislation in India

CO - 3

Know the various parameters in the Drug and Cosmetic Act and rules

CO - 4

Know the Drug policy, DPCO, Patent and design act

CO - 5

Be able to understand the concepts of Dangerous Drugs Act, Pharmacy Act and Excise duties Act.

 

PHARM D - 3rd YEAR

3.6

Pharmaceutical Formulations (THEORY)

CO - 1

  Acquire knowledge about the various pharmaceutical dosage forms and   their  manufacturing  techniques    

CO - 2

Discover various formulation considerations in development of pharmaceutical dosage forms like tablets, capsules.

CO - 3

Understand the quality control tests for the dosage forms.

CO - 4

Detail on parenterals, stringent procedures in the preparation and its evaluation.

CO - 5

Understand clearly about packaging and cosmetic preparations.

 

 

3.6

Pharmaceutical Formulations (PRACTICAL)

CO - 1

 Manufacture  of Tablets

CO - 2

Understand the strict formulation considerations in parenteral  and ophthalmic preparations.

CO - 3

Demonstrate the evaluations of different packaging materials in pharmaceutical industry.

CO - 4

Demonstrate the manufacturing of capsules.

CO - 5

 Preparation of various cosmetic formulations.

 

PHARM D - 4th YEAR

4.4

Bio Statistics & Research  Methodology (THEORY)

CO - 1

Learn general research methodology

CO - 2

Understand the basic concepts of biostatistics

CO - 3

Learn different parametric and non-parametric tests

CO - 4

Understand the functions of ethics committees in medical research

CO - 5

Develop the ability to apply the methods while working on a research project work

CO - 6

Describe the appropriate statistical methods required for a particular research design.

CO - 7

Choose the appropriate research design and develop  appropriate research hypothesis for  a research project.

CO - 8

Develop a appropriate framework for research studies.

 

PHARM D - 4th YEAR

4.5

Biopharmaceutics & Pharmacokinetics (THEORY)

CO - 1

Understand the basic concepts in biopharmaceutics and pharmacokinetics and their  significance

CO - 2

Explain the use of plasma drug concentration-time data to calculate the pharmacokinetic parameters

CO - 3

Understand the concepts of bioavailability and bioequivalence of drug products and their significance

CO - 4

Demonstrate a clear information on compartmental models and methods to assess  the models

CO - 5

Understand various pharmacokinetic parameters, their significance & applications.

4.5

Biopharmaceutics & Pharmacokinetics (PRACTICAL)

CO - 1

Explain the use of plasma drug concentration-time data to calculate the   pharmacokinetic parameters

CO - 2

Understand the concepts of bioavailability and bioequivalence of drug products and their significance

CO - 3

Understand various pharmacokinetic parameters, their significance & applications

CO - 4

Demonstrate a clear information on compartmental models and methods to assess the models.

CO - 5

Describe the kinetics of drug absorption, distribution, metabolism, excretion, elimination.

 

B.PHARM

PROGRAMME EDUCATIONAL OUTCOMES (PEOs)

PEO - 1

To produce pharmacy graduates with strong basics and high technical knowledge to cater the various areas of Pharmaceutical Industry.

PEO - 2

Graduates will be able to discharge the responsibilities of pharmacist with adequate understanding of supportive area as needed in this multidisciplinary area of health care system.

PEO - 3

Pharmacists will be able to a part of the team to communicate well with other professionals in providing medicines needed to society with standards, professional ethics and social responsibilities.

 

PROGRAMME SPECIFIC OUTCOMES (PSOs)

PSO - 1

Apply the knowledge of pharmaceutical and allied sciences in design, manufacture and evaluation of drug delivery systems including cosmetics.

PSO - 2

Appreciate the mechanism of action of drugs including their kinetics and adverse actions. Be able to do basic evaluation of bioactivity of drugs in in - silico models.

 

PROGRAMME OUTCOMES (PO)

B.PHARM

PO - 1

Domain Knowledge: Demonstrate comprehension of basic principles of pharmaceutical and allied sciences in all pertinent scenarios. Exhibit skills associated with the profession of pharmacy, pharmaceutical manufacturing practices and quality control.

PO - 2

Problem analysis: Use domain knowledge, analytical and critical thinking for solving problems and taking decisions during everyday practice in profession, industry and all work environment.

PO - 3

Research and Development: Exhibit knowledge from his major domain in problem identification, critical thinking, analysis and providing solutions to pharmaceutical and allied technology disciplines.

PO - 4

Modern tools usage: Demonstrate an ability to handle/use various tools, apparatus, instrument, equipment or machinery pertinent to the pharmaceutical domain with practical knowledge on standard operating procedures and safety aspects.

PO - 5

The Pharmacist and Society: Use contextual knowledge – informed reasoning to understand medical prescription, perform patient counseling. Recognize the necessity to engage in independent and life-long learning.

PO - 6

Environment and sustainability: Demonstrate knowledge and responsibility while handling pharmaceutical techniques/ processes that have social and environmental impacts and promote sustainable development.

PO - 7

Ethics: Demonstrate exemplary professional, ethical, and legal behaviors in accordance with all drug, pharmaceutical, and pharmacy-related central, state laws and regulations.

PO - 8

Individual and Team skills: Function effectively as an individual member or leader in different teams and multidisciplinary settings. Assume a participatory or lead role in an organization’s planning and execution of transformational projects to enhance its prospects.

PO - 9

Communication: Communicate effectively with the pharmaceutical scientific community, work- force and with society at large, with abilities to comprehend and write effective reports, make effective presentations and documentation.

PO - 10

Project management abilities: Demonstrate effective delegation and organizational skills. Organize work with necessary planning and execution to meet deadlines. Demonstrate knowledge and understanding of pharmaceutical, legal processes and apply them in project management.

 

 COURSE OUTCOMES

B.PHARM  YEAR - I (SEMESTER - I)

BP103T

Pharmaceutics I – Theory

CO - 1

Explain development and latest edition of Pharmacopoeia and other compendia

 

CO - 2

Describe various routes of drug administration, concept of dosage forms, and formulation of solution.

 

CO - 3

Describe various preformulation parameters and classify excipients with its examples

CO - 4

Elaborate different pharmaceutical calculation involved in formulation

CO - 5

Explain type of Pharmaceutical incompatibility

BP109P

Pharmaceutics I – Practical

CO - 1

Demonstrate skill of preparation and evaluation of monophasic liquids.

CO - 2

Demonstrate skill of preparation and evaluation of Biphasic liquids.

CO - 3

Explain principles of formulation and evaluation of powder preparations.

CO - 4

Perform pharmaceutical calculations

CO - 5

Draw the labels in prescribed manner including all the component/parts

 

B.PHARM  YEAR - I (SEMESTER - I)

BP105T

Communication skills – Theory

CO - 1

Understand the behavioral needs for a Pharmacist to function effectively in the

areas of pharmaceutical operation

CO - 2

Communicate effectively (Verbal and Non-Verbal)

CO - 3

Effectively manage the team as a team player

CO - 4

Develop interview skills

CO - 5

Develop Leadership qualities and essentials

 

 

<script src="//cdn.public.n1ed.com/ZwQM

 

B.PHARM  YEAR - I (SEMESTER - I)

BP105T

Communication skills – Theory

CO - 1

Understand the behavioral needs for a Pharmacist to function effectively in the

areas of pharmaceutical operation

CO - 2

Communicate effectively (Verbal and Non-Verbal)

CO - 3

Effectively manage the team as a team player

CO - 4

Develop interview skills

CO - 5

Develop Leadership qualities and essentials

 

BP111P

Communication skills – Practical

CO - 1

 To learn the behavior needs for the pharmacist to function effectively in the areas of pharmaceutical operation.

CO - 2

 To be effective verbal and Non-Verbal communication

CO - 3

 To develop the communication skills to effectively mange the team as team player

CO - 4

 To Communicate in Interview effectively.

CO - 5

 To know and develop the essential qualities of good Leader.

 

B.PHARM  YEAR - I (SEMESTER - I)

BP106RMT

Remedial Mathematics – Theory

CO - 1

To understand the role of mathematics in pharmacy.

CO - 2

To know about theory and their application in pharmacy.

CO - 3

To relate the mathematical tools in the wide professional views and solve problems of trigonometry, calculus and matrices.

CO - 4

To solve the different types of problems by applying theory.

CO - 5

To adopt both conventional and creative techniques to the solutions of mathematical problems.

CO - 6

Apply the range of techniques effectively to solve problems including theory deduction, approximation and simulation.

CO - 7

Gain knowledge on how to solve different types of problems by applying theory and applications of mathematics in pharmacy.

 

B.PHARM - YEAR - I (SEMESTER - II)

BP205T

Computer Applications in Pharmacy – Theory

CO - 1

Apply the knowledge of mathematics and computing fundamentals to pharmaceutical applications for any given requirement.

CO - 2

Design and develop solutions to analyze pharmaceutical problems using computers.

CO - 3

Integrate and apply efficiently the contemporary IT tools to all pharmaceutical related activities.

CO - 4

Know the various databases in pharmacy

 

 

BP210P

Computer Applications in Pharmacy – Practical

CO - 1

Retrieve the information of a drug and its adverse effect using online tools.

CO - 2

Able to acquire knowledge of computer application in clinical studies and use of databases.

CO - 3

Work with MS Access.

CO - 4

Exporting Tables, Queries, Forms and Report to web pages and HTML

CO - 5

Creating labels, databases regarding patient information.

 

B.PHARM - YEAR - I (SEMESTER - II)

BP206T

Environmental sciences – Theory

CO - 1

Analyze the interrelationship between living organism and environment.

CO - 2

Understand the importance of environment by assessing its impact on the human world.

CO - 3

Enrich the knowledge on themes of biodiversity, natural resources, pollution control and waste management.

CO - 4

Understand the constitutional protection given for environment.

CO - 5

An Environmental Studies major will be able to recognize the physical, chemical, and biological components of the earth’s systems and show how they function

 

B.PHARM - YEAR - II (SEMESTER - III)

BP302T

Physical Pharmaceutics I – Theory

CO - 1

Investigate and apply various theories, laws and equations related to different states of matter

CO - 2

Understand the mechanisms of solute solvent interactions

CO - 3

Understand the concept of surface and interfacial tension and their applications in pharmaceuticals.

CO - 4

Understand the various intermolecular forces involved in the formation of complexes and its applications

CO - 5

Understanding and applying the knowledge of Buffers and Isotonic solutions in the formulation and development of various dosage form.

BP306P

Physical Pharmaceutics I – Practical

CO - 1

Calculate surface tension of given liquid, critical micelle concentration and HLB value of given surfactant

CO - 2

Determine partition coefficient of drug in O/W system and understanding its importance in formulation development.

CO - 3

Understanding the phase rule and determining % composition of NaCl in a solution using phenol-water system by CST method.

CO - 4

Determining pKa value of drug substances using Half Neutralization/ Henderson Hasselbalch equation and applying this knowledge in formulating suitable drug delivery system to improve bioavailability

CO - 5

Determination of stability constant and donor acceptor ratio of various complexes by pH titration and solubility method.

 

B.PHARM - YEAR - II (SEMESTER - III)

BP303T

Pharmaceutical Microbiology – Theory

CO - 1

Explain methods of identification, cultivation and preservation of various microorganisms

CO - 2

Understand the effectiveness of sterilization processes implemented in pharmaceutical industry.

CO - 3

Understand mode of action disinfectants, sterility testing & microbiological assays of various pharmaceutical products.

CO - 4

Summarize types of microbial spoilages & preservation of pharmaceutical products.

CO - 5

Outline the cell culture technology and its applications in pharmaceutical industries.

BP307P

Pharmaceutical Microbiology – Practical

CO - 1

Apply the knowledge in operating various instruments & scientific techniques.

CO - 2

Demonstrate various staining procedures for studying morphology of bacteria & observe the motility of bacteria.

CO - 3

Isolate bacteria by streak plate technique & count them by pour plate technique

CO - 4

Carry out microbiological standardization of Pharmaceuticals

CO - 5

Perform bacteriological analysis of water and sterility testing of pharmaceutical products.

 

B.PHARM - YEAR - II (SEMESTER - III)

BP304T

Pharmaceutical Engineering – Theory

CO - 1

Understand the various laws, mechanisms of unit operations.

CO - 2

Understand the material handling techniques.

CO - 3

Explain the various processes involved in Pharmaceutical manufacturing process.

CO - 4

Understand the concepts of heat transfer and fluid flow.

CO - 5

Describe various preventive methods used for corrosion control in Pharmaceutical industries

BP 308P

Pharmaceutical Engineering –Practical

CO - 1

To understand the principle, mechanism, factors affecting and applications of the various unit operations

CO - 2

To appraise various laws governing the unit operations

CO - 3

To understand the construction, working and application of Pharmaceutical Machinery

CO - 4

To demonstrate the various pharmaceutically important processes and equipments.

CO - 5

To understand the mechanism of Heat transfer.

 

B.PHARM - YEAR - II (SEMESTER - IV)

BP403T

Physical Pharmaceutics II – Theory

CO - 1

Relate various physicochemical properties of drug and excipient molecules in designing the dosage forms.

CO - 2

Distinguish the principles of chemical kinetics & to use them for stability testing and determination of expiry date of formulations.

CO - 3

Demonstrate the behavior and mechanism of drugs and excipients in the formulation development and evaluation of dosage forms.

CO - 4

Understand the concept of rheology and its applications in pharmaceutical industries.

CO - 5

Understanding the micromeritics and its applications in designing various drug delivery systems.

BP407P

Physical Pharmaceutics II – Practical

CO - 1

Determine of particle size, particle size distribution, flow properties  bulk density, true density and porosity using various methods

CO - 2

Determine viscosity of liquids and semisolids by various methods.

CO - 3

Determine sedimentation rate and sedimentation volume, Cloud and Kraft points of given surfactants,

CO - 4

Determine  reaction rate constant

CO - 5

To carry out stability studies.

 

YEAR - III (SEMESTER - V)

BP502T

Industrial Pharmacy I– Theory

CO - 1

Carry out assessment of physicochemical properties of drugs as a tool in the optimization of solid and liquid dosage forms.

CO - 2

Formulate and prepare tablets, capsules and liquid orals using established procedures and technology.

CO - 3

Describe the facilities and standards necessary for the industrial production of sterile dosage forms.

CO - 4

Formulate and prepare different types of parenteral and ophthalmic dosage forms

CO - 5

Select and evaluate appropriate packaging materials for various pharmaceutical dosage forms.

BP506P

Industrial Pharmacy I – Practical

CO - 1

Demonstrate the correct use of various equipment in pharmaceutics laboratory

relevant to tablets, capsules,

CO - 2

Demonstrate the correct use of various equipment in pharmaceutics laboratory

relevant to parenteral, semisolids and pharmaceutical  packaging material evaluation

CO - 3

Explain formulation, evaluation and labeling of tablets & capsules, parenteral

and semisolids as per regulatory requirements.

CO - 4

Understand use of excipients in formulation of tablet, capsules, semisolids and

parenteral preparations

CO - 5

Perform evaluation of glass containers as per IP.

 

B.PHARM - YEAR - III (SEMESTER - VI)

BP604T

Biopharmaceutics and Pharmacokinetics – Theory

CO - 1

Understand the concept of bio pharmaceutics and its applications in formulation development

CO - 2

Discuss various pharmacokinetic processes and their relevance in dosage form

design.

CO - 3

Design dosage regimens for patients based on calculated pharmacokinetic parameters.

CO - 4

Select the correct pharmacokinetic model based on plasma level or urinary excretion data that best describes the process of drug absorption, distribution, metabolism and elimination (ADME).

CO - 5

Calculate various pharmacokinetic parameters from plasma and urinary excretion data applying compartment modeling and model independent methods to describe the kinetics of drug absorption, distribution, metabolism, excretion or elimination

 

B.PHARM - YEAR - III (SEMESTER - VI)

BP605T

Pharmaceutical Biotechnology – Theory

CO - 1

Discuss the importance and Application of Immobilized enzymes.

CO - 2

Understand concepts of recombinant DNA technology, genetic engineering,

CO - 3

Describe  the concept of  immunity and production of vaccine. Explain production of Monoclonal antibodies

CO - 4

Discuss various immune blotting techniques Knowledge about  genetic multiplication and biotransformation

CO - 5

 Explain the process of Fermentation technology and its applications in production of pharmaceuticals.

 

B.PHARM - YEAR - IV (SEMESTER - VII)

BP702T

Industrial Pharmacy II – Theory

CO - 1

Discuss the process of pilot plant scale up of pharmaceutical dosage forms.

CO - 2

Understand the process of technology transfer from lab scale to commercial

batch

CO - 3

Explain the different laws and acts that regulate pharmaceutical industry.

CO - 4

Describe the approval process and regulatory requirements of drug products.

CO - 5

Describe the organization and responsibilities of national and state licensing authority.

 

B.PHARM - YEAR - IV (SEMESTER - VII)

BP704T

Novel Drug Delivery System – Theory

CO - 1

Explain the principles and technology used in the design of sustained release and controlled release drug delivery systems

CO - 2

Understand the criteria for selection of drugs and polymers for the development of Novel drug delivery systems.

CO - 3

Understand the formulation, evaluation and applications of various novel drug delivery systems

CO - 4

Explain the formulation and characterization of transdermal  drug Delivery systems

CO - 5

Discuss various approaches for the development of targeted drug Delivery

 

B.PHARM - YEAR - IV (SEMESTER - VII)

BP706PS

Practice School

CO - 1

To understand the importance of realistic learning through practice in various domains such as community pharmacy, drug testing and manufacturing, preclinical testing, clinical practice, patent filing, regulatory filing accounting, green audit and article writing.

CO - 2

To get familiarize with the aspects of realistic practice in the domain of interest.

CO - 3

To develop knowledge and skills related to practical learning in the domain of interest.

CO - 4

To analyze the problems encountered during realistic practice and make use of theoretical knowledge to resolve those problems.

CO - 5

To build up the ability to perform well in the domain of interest after becoming an employee/entrepreneur.

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP801T

Biostatistics and Research Methodology

CO - 1

Learn general research methodology

CO - 2

Understand the basic concepts of biostatistics

CO - 3

Learn different parametric and non-parametric tests

CO - 4

Understand the functions of ethics committees in medical research

CO - 5

Develop the ability to apply the methods while working on a research project work

CO - 6

Describe the appropriate statistical methods required for a particular research design.

CO - 7

Choose the appropriate research design and develop appropriate research hypothesis for  a research project.

CO - 8

Develop a appropriate framework for research studies.

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP803ET

Pharma Marketing Management

CO - 1

Describe the concept of pharmaceutical marketing.

CO - 2

Enumerate the concept of product management in pharmaceutical industry

CO - 3

Discuss the various components of promotion of pharmaceutical products

CO - 4

Explain the different pharmaceutical marketing channels. Discuss the emerging concepts of marketing

CO - 5

Discuss the roles and responsibilities of pricing authorities in India

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP804ET

Pharmaceutical Regulatory Science

CO - 1

To recall the concepts of Drug discovery, development process, clinical studies and generic drug product development.

CO - 2

To perceive the regulatory approval process and timelines for IND, NDA and ANDA and to know about changes to an approved NDA/ANDA.

CO - 3

To familiar with Regulatory authorities and agencies like India, USA, Europe, Australia, Japan and Canada.

CO - 4

To know the regulatory registration process of Indian drugs in overseas market which include to understand about technical documents like DMF, CTD, eCTD and ACTD.

CO - 5

To assimilate the process of clinical trials and pharmacovigilance as well as to understand obligations of GCP in clinical trials.

CO - 6

To understand the concepts of Regulatory science in pharmaceutical industry as well as to make use of regulatory guidelines, laws, acts, orange and purple book.

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP807ET

Computer Aided Drug Design

CO - 1

The students can be able to recall the approaches in drug discovery, drug development, lead discovery based on metabolism and clinical observation and also analog based drug design

CO - 2

Studied the development, approaches of QSAR, importance and determination of physicochemical parameters

CO - 3

The students can be able to make use of molecular modeling and virtual screening techniques

CO - 4

The students can be able to apply the molecular docking techniques to examine the binding interactions of ligand with molecular targets

CO - 5

The students can be able to explain the applications of bioinformatics, chemo

informatics, ADME databases, chemical, biochemical and pharmaceutical databases relevant to drug design

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP809ET

Cosmetic Science

CO - 1

Understand the concepts of cosmetics, cosmoceuticals and its classification.

CO - 2

Describe the role of cosmetic excipients and building blocks in the formulation of cosmetics

CO - 3

Understand the formulation and evaluation of different cosmetic products.

CO - 4

Evaluate cosmetics for various physico-chemical properties.

CO - 5

Design  of cosmetics and cosmeceuticals that address the problems of dry skin, acne, dermatitis, prickly heat, wrinkles, blemishes,  hair fall, Dandruff, body odour, bleeding gums, mouth odour, teeth discoloration and sensitive teeth.

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP812ET

Dietary Supplements and Nutraceuticals

CO - 1

Understand the need of supplements by the different group of people to maintain healthy life.

CO - 2

Understand the outcome of deficiencies in dietary supplements.

CO - 3

Appreciate the components in dietary supplements and the application.

CO - 4

Appreciate the regulatory and commercial aspects of dietary supplements including health claims.

 

B.PHARM - YEAR - IV (SEMESTER - VIII)

BP813PW

Project Work

CO - 1

  Know the source of literature and literature survey

CO - 2

Able to design research protocol and carry out study as per design

CO - 3

Can analyze and interpret research data using appropriate statistical tools

CO - 4

Capable of writing scientific documents

CO - 5

Developed tendency to work in group

Publication

S.No Tittle of Paper Name of The Author Name of the Journal Year of publication ISSN number
  1 Formulation And Evalution Of Aceclofenac Sustained Delease Matrix Tables Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2017 2456-8147
  2 Formulation And Evaluation Of Lornoxicam Dispersible Tablets Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2017 2456-8147
    3 Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  4 Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  5 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  6 Formulation And Evaluation Of Anti-Fungal Property Containing Fluconazole Gel Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  7 Formulation And Evaluation Of Oral Disintegrating Tablets And Oral Disintegrating Films Of Lisinopril Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  8 Formulation And Evalution Of Aceclofenac Sustained Delease Matrix Tables Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2017 2456-8147
  9 Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio Dr.S.Chandra International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  10 Formulation And Evaluation Of Diclofenac Sodium Transdermal Patches Dr.S.Chandra World Journal Of Pharmaceutical Research 2018 2277-7105
  11 Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery Dr.S.Chandra World Journal Of Pharmaceutical Research 2019 2277-7105
  12 Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  13 Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  14 Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  15 Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  16 Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  17 Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride Dr.S.Chandra World Journal Of Pharmaceutical Research 2020 2277-7105
  18 Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  19 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  20 Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  21 Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  22 An Review Of Transdermal Drug Delivery System Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  23 A Review On Sustained Release Drug Delivery System Dr.S.Chandra World Journal Of Pharmaceutical Research 2021 2277-7105
  24 Formulation And Evaluation Of Sustained Release Bilayer Tablet Of Flupirtine Maleate R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
    25 Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  26 Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  27 Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  28 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  29 Formulation And Evaluation Of Anti Fungal Property Containing Fluconazole Gel R.Suresh International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  30 Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery R.Suresh World Journal Of Pharmaceutical Research 2019 2277-7105
  31 Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride R.Suresh World Journal Of Pharmaceutical Research 2020 2277-7105
  32 Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum R.Suresh World Journal Of Pharmaceutical Research 2020 2277-7105
  33 Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration R.Suresh World Journal Of Pharmaceutical Research 2020 2277-7105
  34 Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone R.Suresh World Journal Of Pharmaceutical Research 2020 2277-7105
  35 Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride R.Suresh World Journal Of Pharmaceutical Research 2020 2277-7105
  36 An Review Of Transdermal Drug Delivery System R.Suresh World Journal Of Pharmaceutical Research 2021 2277-7105
  37 A Review On Sustained Release Drug Delivery System R.Suresh World Journal Of Pharmaceutical Research 2021 2277-7105
  38 Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation R.Suresh World Journal Of Pharmaceutical Research 2021 2277-7105
  39 Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy R.Suresh World Journal Of Pharmaceutical Research 2021 2277-7105
  40 Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion R.Suresh World Journal Of Pharmaceutical Research 2021 2277-7105
  41 Formulation And Evaluation Of Sustained Release Bilayer Tablet Of Flupirtine Maleate S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  42 Formulation And Evaluation Of Ofloxacin Microsphere By Using Ethyl Cellulose As A Polymer At Different Ratio S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  43 Formulation And Evalution Of Oral Medicated Jellies Of Cyproheptadine Hcl S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  44 Formulation And Evaluation Of Rosuvastatin Sustained Release Matrix Tablet S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
  45 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Cefdinir Antibiotic S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
    46 Formulation And Evaluation Of Anti Fungal Property Containing Fluconazole Gel S.Sangeetha International Journal Of Advanced Pharmaceutical Science 2018 2456-8147
    47 Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery S.Sangeetha World Journal Of Pharmaceutical Research 2019 2277-7105
  48 Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium S.Sangeetha World Journal Of Pharmaceutical Research 2020 2277-7105
  49 Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum S.Sangeetha World Journal Of Pharmaceutical Research 2020 2277-7105
  50 Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration S.Sangeetha World Journal Of Pharmaceutical Research 2020 2277-7105
  51 Design And Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System For Predisolone S.Sangeetha World Journal Of Pharmaceutical Research 2020 2277-7105
  52 Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride S.Sangeetha World Journal Of Pharmaceutical Research 2020 2277-7105
  53 An Review Of Transdermal Drug Delivery System S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  54 A Review On Sustained Release Drug Delivery System S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  55 Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  56 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  57 Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  58 Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  59 Formulation Charecterization And Invitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymer Concentration S.Sangeetha World Journal Of Pharmaceutical Research 2021 2277-7105
  60 Design ,Development And Evaluation Of Selected Antifungal Loaded Ethosomal Gel For Topical Drug Delivery S.Kavibharathi World Journal Of Pharmaceutical Research 2019 2277-7105
  61 Development Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol Hydrochloride S.Kavibharathi World Journal Of Pharmaceutical Research 2020 2277-7105
  62 Formulation And Evalution Studies Of Enteric Coated Tablet Containing Non-Steroidal Anti Inflammatory Diclofenac Sodium S.Kavibharathi World Journal Of Pharmaceutical Research 2020 2277-7105
  63 Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea Gum S.Kavibharathi World Journal Of Pharmaceutical Research 2020 2277-7105
  64 Formulation And Evaluation Of Ketorolac Tromethamine Ophthalmic Solution Using Different Concentration Of Benzalkonium Chloride S.Kavibharathi World Journal Of Pharmaceutical Research 2020 2277-7105
  65 Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  66 Formulation And Evaluation Studies Of Floating Drug Delivery System Containing Nizatidine Anti Ulcer Drug S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  67 Development Of Nanomaterial Based Topical Drug Delivery System For Diabetic Retinopathy S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  68 Approach To Enhance The Solubility Of Carvedilol Using Beta -Cd Complexation S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  69 A Review On Sustained Release Drug Delivery System S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  70 Formulation And Evaluation Of Liquid Crystalline Nanoparticle For The Treatment Of Diabetic Retinopathy S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  71 Formulation Evaluation Of Amlodipine Besylate Solid Dispersion S.Kavibharathi World Journal Of Pharmaceutical Research 2021 2277-7105
  72 Formulation And Evaluation Of Oral Medicated Jellies Of Cyproheptadine Hcl A.Sheik Alisha International Journal Of Advanced Pharmaceutical Sciences 2018 2456-8147
  73 Formulation And Evaluation  Of Olfloxacin Microspheres By Using Ethyl Cellulose As A Polymers At Different Ratio A.Sheik Alisha International Journal Of Advanced Pharmaceutical Sciences 2018 2456-8147
  74 Designs, Characterization And Evaluation Of Mucoadhesive Colon Targeted Drug Delivery System  For Prednisolone     A.Sheik Alisha World Journal Of Pharmaceutical Research 2020 2277-7105
  75 Formulation Characterisation And In Vitro Evaluation Of Transdermal Patches Of Ketoprofen With Different Polymers Concentration A.Sheik Alisha World Journal Of Pharmaceutical Research 2019 2227-7105
  76 Formulation And Evaluation Studies Of Enteric Coated Tablets Containing Non-Steroidal Anti-Inflammatory Diclofenac Sodium A.Sheik Alisha World Journal Of Pharmaceutical Research 2020 2227-7105
  77 Formulation And Evaluation Of Diltiazem Hcl Buccal Patches By Using Lannea  Gum A.Sheik Alisha World Journal Of Pharmaceutical Research 2019 2227-7105
  78 Devilopment Of Sustained Release Matrix Tablet Formulation And Evaluation Of Ambroxol  Hydrochloride A.Sheik Alisha World Journal Of Pharmaceutical Research 2019 2227-7105
  79 A Review On Sustained Release Drug Delivery System A.Sheik Alisha World Journal Of Pharmaceutical Research 2020 2227-7105
  80 Formulation And Evaluation Of Amlodipine Besylate Solid Dispersion A.Sheik Alisha World Journal Of Pharmaceutical Research   2020   2227-7105

Lab Facility

  • Tablet Multipunching Machine
  • Brook Field Viscometer
  • Glass Distillation Apparatus
  • UV- Visible Spectrophotometry
  • Infra- Red Moisture Balance
  • Disintegration Test Apparatus
  • Dissolution Apparatus
  • Bottle Washing Machine
  • Ultra Sonicator
  • Tincture Press
  • Ball Mill
  • Cutter Mill
  • Ointment Filling Machine
  • Liquid Filling Machine
  • Sieve Shaker
  • Laminar Air Flow
  • Kalwega Unit
  • Ph Meter
  • B.O.D Incubator
  • Pan Coating
  • Single Tablet Punching Machine

INSTRUMENT PHOTOS

...

INVITRO DISSOLUTION APPARATUS

...

UV SPECTROSCOPY

...

UV SPECTROSCOPY

...

SINGLE TABLET PUNCHING MACHINE

...

INVITRO DISSOLUTION APPARATUS

...

OINTMENT FILLING MACHINE

MOU

S.NO Academic year Organization with which MoU is signed Date of Signing Date of Signing MOU Duration
1 2018-2019 COLUMBIA ASIA HOSPITAL, MYSURU 30/10/2018 5 Years
2 2019-2020 ATOZETA HEALTH SOLUTIONS PVT. LTD 01/10/2019 5 Years
3 2019-2020 FREEDOM CARE 27/09/2019 5 Years
4 2020-2021 CLINOSOL RESEARCH PRIVATE LIMITED 05/10/2020 5 Years
4 2021-2022 MAARUTHI MEDICAL CENTRE AND HOSPITALS,ERODE 19/01/2021 5 Years